IA
RLAY icon

IFP Advisors’s Relay Therapeutics RLAY Stock Holding History

IFP Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5K Sell
563
-13
-2% -$189 ﹤0.01% 3365
2026
Q1 		$5.73K Hold
576
– – ﹤0.01% 3438
2025
Q4 		$4.87K Hold
576
– – ﹤0.01% 3427
2025
Q3 		$3.01K Buy
576
+407
+241% +$1.55K ﹤0.01% 3518
2025
Q2 		$585 Buy
+169
New +$503 ﹤0.01% 4392
2025
Q1 		– Hold
0
– – – 4177
2024
Q4 		– Hold
0
– – – 4390

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

IFP Advisors's RLAY Position: Q2 2026 in Review

IFP Advisors reduced its Relay Therapeutics (RLAY) stake by 2.3% in Q2 2026, selling an estimated $189 and leaving 563 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3365.

IFP Advisors first reported a position in RLAY in Q2 2025 and has held it in 5 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • IFP Advisors held 563 shares of Relay Therapeutics worth $10.5K as of Q2 2026.
  • IFP Advisors sold 13 Relay Therapeutics shares in Q2 2026, an estimated $189.
  • Relay Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3365 holding.
  • IFP Advisors first reported a position in Relay Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.